lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - imunossupressores - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
itraconazol
eurofarma laboratÓrios s.a. - itraconazol - antimicoticos sistemicos
sporanox
janssen-cilag farmacÊutica ltda - itraconazol - antimicoticos sistemicos
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
itraconazol
ems s/a - itraconazol - antimicotico
itralex
ems s/a - itraconazol - antimicotico
itraconazol
geolab indÚstria farmacÊutica s/a - itraconazol - antimicoticos sistemicos
itraconazol
germed farmaceutica ltda - itraconazol - antimicotico
itraconazol
legrand pharma indÚstria farmacÊutica ltda - itraconazol - antimicotico
funok
multilab industria e comercio de produtos farmaceuticos ltda - itraconazol - antimicotico